{"review_status":"criteria provided, single submitter","id":"SCV000062127","clinical_assertion_trait_set_id":"SCV000062127","local_key":"26351883|Orphanet:ORPHA3071","internal_id":"103327","interpretation_comments":["{\"text\":\"The Thr58Ile variant in HRAS has been reported in three individuals with clinica l features of Costello syndrome (Gripp 2008, Gripp 2012, LMM unpublished data). It was identified to occur de novo in two of these individuals and segregated w ith disease in one affected relative from one of these families. This variant wa s absent from large population studies. Computational prediction tools and conse rvation analysis suggest that this variant may impact the protein, though this i nformation is not predictive enough to determine pathogenicity. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partner s.org/LMM).\"}"],"variation_archive_id":"VCV000012610","submitter_id":"21766","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}}]}}","submission_id":"21766.2019-03-21","date_last_updated":"2020-01-18","date_created":"2013-03-16","record_status":"current","rcv_accession_id":"RCV000013444","trait_set_id":"3420","submission_names":["SUB5348977"],"interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2014-09-23","version":"5","assertion_type":"variation to disease","variation_id":"12610","clinical_assertion_observation_ids":["SCV000062127.0"],"submitted_assembly":"GRCh37"}
{"review_status":"criteria provided, single submitter","id":"SCV001119032","clinical_assertion_trait_set_id":"SCV001119032","local_key":"2035389|MedGen:CN517202","internal_id":"2086965","interpretation_comments":[],"variation_archive_id":"VCV000046503","submitter_id":"500031","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Nykamp K et al. (Genet Med 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","submission_id":"500031.2019-03-14","date_last_updated":"2019-12-19","date_created":"2019-12-14","record_status":"current","rcv_accession_id":"RCV000727222","trait_set_id":"9460","submission_names":["SUB5321749"],"interpretation_description":"Benign","interpretation_date_last_evaluated":"2019-03-05","version":"1","assertion_type":"variation to disease","variation_id":"46503","clinical_assertion_observation_ids":["SCV001119032.0"],"submitted_assembly":"GRCh37"}
{"review_status":"criteria provided, single submitter","id":"SCV000063451","clinical_assertion_trait_set_id":"SCV000063451","local_key":"30968208|not specified","internal_id":"104651","interpretation_comments":["{\"text\":\"p.Ala1855Ala in exon 33 of PCDH15: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located ne ar a splice junction and has been identified in 0.3% (381/126618) European chro mosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute .org; dbSNP rs111033445).\"}"],"variation_archive_id":"VCV000046503","submitter_id":"21766","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","date_last_updated":"2020-01-18","date_created":"2013-03-16","record_status":"current","rcv_accession_id":"RCV000039762","trait_set_id":"9590","submission_names":["SUB5348979"],"interpretation_description":"Likely benign","interpretation_date_last_evaluated":"2017-09-04","version":"6","assertion_type":"variation to disease","variation_id":"46503","clinical_assertion_observation_ids":["SCV000063451.0"],"submitted_assembly":"GRCh37"}
{"review_status":"criteria provided, single submitter","id":"SCV000065162","clinical_assertion_trait_set_id":"SCV000065162","local_key":"11832988|not specified","internal_id":"106362","interpretation_comments":["{\"text\":\"The p.Arg544Cys variant in OTOF has been identified in 1 individual with autosom al recessive sensorineural hearing loss who carried a second OTOF variant of unc ertain significance; it is unclear whether these variants are in trans (Sommen 2 016). The p.Arg544Cys variant has also been identified by our laboratory in 6 in dividuals with hearing loss; however, none of these individuals carried a varian t affecting the other copy of the OTOF gene or was reported to have auditory neu ropathy typically associated with OTOF related hearing loss. This variant has be en reported in ClinVar (Variation ID: 48176). It has been identified in 0.15% (1 93/125430) of European chromosomes by the Genome Aggregation Database (gnomAD, h ttp://gnomad.broadinstitute.org); however, this frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation anal ysis suggest that the p.Arg544Cys variant may impact the protein, though this in formation is not predictive enough to determine pathogenicity. In summary, the c linical significance of the p.Arg544Cys variant is uncertain. ACMG/AMP Criteria applied: PP3, BS1_Supporting.\"}"],"variation_archive_id":"VCV000048176","submitter_id":"21766","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","date_last_updated":"2020-01-18","date_created":"2013-03-16","record_status":"current","rcv_accession_id":"RCV000041467","trait_set_id":"9590","submission_names":["SUB5348979"],"interpretation_description":"Uncertain significance","interpretation_date_last_evaluated":"2018-08-21","version":"6","assertion_type":"variation to disease","variation_id":"48176","clinical_assertion_observation_ids":["SCV000065162.0"],"submitted_assembly":"GRCh37"}
{"review_status":"criteria provided, single submitter","id":"SCV000061597","clinical_assertion_trait_set_id":"SCV000061597","local_key":"15072993|MeSH:D002289","internal_id":"102797","interpretation_comments":["{\"text\":\"This variant has been reported as a somatic change in large intestine, skin, end ometrium, stomach, and ovary (COSMIC, Fransen 2004) and has been observed in up to 11% of BRAF mutant positive lung adenocarcinoma (Paik 2011).\"}"],"variation_archive_id":"VCV000013972","submitter_id":"21766","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"14688025\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","date_last_updated":"2020-01-18","date_created":"2013-03-16","record_status":"current","rcv_accession_id":"RCV000037932","trait_set_id":"4069","submission_names":["SUB5348977"],"interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2012-06-11","version":"4","assertion_type":"variation to disease","variation_id":"13972","clinical_assertion_observation_ids":["SCV000061597.0"],"submitted_assembly":"GRCh37"}
{"review_status":"criteria provided, single submitter","id":"SCV000600091","clinical_assertion_trait_set_id":"SCV000600091","local_key":"2564206|not provided","internal_id":"1163765","interpretation_comments":[],"variation_archive_id":"VCV000000822","submitter_id":"500110","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}}}","submission_id":"500110.2019-10-16","date_last_updated":"2020-01-06","date_created":"2017-09-27","record_status":"current","rcv_accession_id":"RCV000034388","trait_set_id":"9460","submission_names":["SUB6432949"],"interpretation_description":"Uncertain significance","interpretation_date_last_evaluated":"2019-08-04","version":"2","assertion_type":"variation to disease","variation_id":"822","clinical_assertion_observation_ids":["SCV000600091.0"],"submitted_assembly":"GRCh37"}
{"review_status":"criteria provided, single submitter","id":"SCV000296305","clinical_assertion_trait_set_id":"SCV000296305","local_key":"2420169|not provided","internal_id":"573876","interpretation_comments":["{\"text\":\"The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one symptomatic patient, and found in general population data that is consistent with pathogenicity.\"}"],"variation_archive_id":"VCV000017674","submitter_id":"500110","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"26295337\",\"@Source\":\"PubMed\"}}}","submission_id":"500110.2019-10-16","date_last_updated":"2020-01-06","date_created":"2016-07-29","record_status":"current","rcv_accession_id":"RCV000159924","trait_set_id":"9460","submission_names":["SUB6432949"],"interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2019-03-20","version":"4","assertion_type":"variation to disease","variation_id":"17674","clinical_assertion_observation_ids":["SCV000296305.0"],"submitted_assembly":"GRCh37"}
{"review_status":"criteria provided, single submitter","id":"SCV000540939","clinical_assertion_trait_set_id":"SCV000540939","local_key":"NM_007294.3:c.4065_4068delTCAA|Familial cancer of breast","internal_id":"1053858","interpretation_comments":[],"variation_archive_id":"VCV000017674","submitter_id":"1006","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}],\"StudyDescription\":{\"$\":\"Variants for BRCA1/2 tests\"}}","submission_id":"1006.2017-02-23","date_last_updated":"2020-01-18","date_created":"2017-04-13","record_status":"current","rcv_accession_id":"RCV000476410","trait_set_id":"774","submission_names":["BRCA12"],"interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2017-02-23","version":"1","assertion_type":"variation to disease","variation_id":"17674","clinical_assertion_observation_ids":["SCV000540939.0"],"submitted_assembly":"GRCh37"}
{"review_status":"no assertion criteria provided","id":"SCV000863590","clinical_assertion_trait_set_id":"SCV000863590","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:CN221562","internal_id":"1688796","interpretation_comments":[],"variation_archive_id":"VCV000017674","submitter_id":"500086","content":"{\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","submission_id":"500086.2018-07-18","date_last_updated":"2020-01-10","date_created":"2018-12-20","record_status":"current","rcv_accession_id":"RCV000735453","trait_set_id":"20192","submission_names":["SUB4310295"],"interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2010-07-08","version":"1","assertion_type":"variation to disease","variation_id":"17674","clinical_assertion_observation_ids":["SCV000863590.0"],"submitted_assembly":"GRCh37"}
{"review_status":"criteria provided, single submitter","id":"SCV000711777","clinical_assertion_trait_set_id":"SCV000711777","local_key":"66138958|not specified","internal_id":"1392883","interpretation_comments":["{\"text\":\"c.2232+9C\u003eT in intron 18 of MYH14: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence.\"}"],"variation_archive_id":"VCV000504895","submitter_id":"21766","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","date_last_updated":"2020-01-18","date_created":"2018-04-03","record_status":"current","rcv_accession_id":"RCV000614433","trait_set_id":"9590","submission_names":["SUB5348977"],"interpretation_description":"Likely benign","interpretation_date_last_evaluated":"2016-04-14","version":"1","assertion_type":"variation to disease","variation_id":"504895","clinical_assertion_observation_ids":["SCV000711777.0"],"submitted_assembly":"GRCh37"}
{"review_status":"no assertion criteria provided","id":"SCV000328841","clinical_assertion_trait_set_id":"SCV000328841","local_key":"chrX:152989013G\u003eT|OMIM:300475","internal_id":"962969","interpretation_comments":["{\"text\":\"Our laboratory reported dual molecular diagnoses in PLA2G6 (homozygous exon 2 deletion) and BCAP31 (NM_001139457.2, c.107C\u003eA) in one individual with reported features which included delayed motor milestones, developmental regression, dysphagia, central hypotonia, vision loss, esotropia, cryptorchidism, cerebellar atrophy with a flattened pons and hypoplasia of the inferior vermis. The BCAP31 variant is predicted to cause a nonsense mutation and is categorized as deleterious by ACMGG guidelines [PMID: 18414213].\"}"],"variation_archive_id":"VCV000374401","submitter_id":"1006","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"X-linked inheritance\",\"@Type\":\"ModeOfInheritance\"}}}","submission_id":"1006.2016-11-14","date_last_updated":"2020-01-18","date_created":"2017-01-11","record_status":"current","rcv_accession_id":"RCV000415452","trait_set_id":"11792","submission_names":["Dual_diagnosis_variants"],"interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2014-06-17","version":"1","assertion_type":"variation to disease","variation_id":"374401","clinical_assertion_observation_ids":["SCV000328841.0"],"submitted_assembly":"hg19"}
{"review_status":"no assertion criteria provided","id":"SCV000190379","clinical_assertion_trait_set_id":"SCV000190379","local_key":"UWMG_1586863","internal_id":"347842","interpretation_comments":[],"variation_archive_id":"VCV000042540","submitter_id":"505295","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},\"Comment\":{\"$\":\"Variants classified for the Actionable exomic incidental findings in 6503 participants: challenges of variant classification manuscript\"},\"StudyDescription\":{\"$\":\"Variants classified for the Actionable exomic incidental findings in 6503 participants: challenges of variant classification manuscript\"},\"StudyName\":{\"$\":\"ESP 6500 variant annotation\"}}","submission_id":"505295.2014-08-28","date_last_updated":"2020-01-04","date_created":"2014-12-04","record_status":"current","rcv_accession_id":"RCV000035406","trait_set_id":"2675","submission_names":["ESP 6500 variant annotation"],"interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2014-06-01","version":"1","assertion_type":"variation to disease","variation_id":"42540","clinical_assertion_observation_ids":["SCV000190379.0"]}
{"review_status":"criteria provided, single submitter","id":"SCV000059054","clinical_assertion_trait_set_id":"SCV000059054","local_key":"2991309|Orphanet:ORPHA217569","internal_id":"100254","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant in MYBPC3 has been well reported in many individuals acr oss multiple studies and is known to be pathogenic for hypertrophic cardiomyopat hy (HCM). It is also the most common pathogenic HCM variant identified by our la boratory. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant HCM based upon multiple reports in affected individuals and extensive segregation studies (Richard 2003, Van Driest 2004, Carballo 2005, Ingles 2005, Maron 2008, Kaski 2009, Marston 2009, Saltzman 2010). ACMG/AMP cri teria applied: PS4, PP1_Strong.\"}"],"variation_archive_id":"VCV000042540","submitter_id":"21766","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20031618\",\"@Source\":\"PubMed\"}}]},\"ReplacedList\":{\"Replaced\":{\"@Accession\":\"SCV000198910\",\"@DateChanged\":\"2015-02-23\",\"@Version\":\"1\"}}}","submission_id":"21766.2019-03-21","date_last_updated":"2020-01-18","date_created":"2013-03-16","record_status":"current","rcv_accession_id":"RCV000203913","trait_set_id":"17368","submission_names":["SUB5348977"],"interpretation_description":"Pathogenic","interpretation_date_last_evaluated":"2011-06-16","version":"5","assertion_type":"variation to disease","variation_id":"42540","clinical_assertion_observation_ids":["SCV000059054.0"],"submitted_assembly":"GRCh37"}
{"review_status":"no assertion provided","id":"SCV000606931","clinical_assertion_trait_set_id":"SCV000606931","local_key":"genomeconnect_15537_623","internal_id":"1174093","interpretation_comments":["{\"text\":\"GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.\"}"],"variation_archive_id":"VCV000042540","submitter_id":"506185","content":"{\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"506185.2017-08-22","date_last_updated":"2020-01-25","date_created":"2017-10-13","record_status":"current","rcv_accession_id":"RCV000203913","trait_set_id":"17368","submission_names":["GenomeConnect_hg19_81817"],"interpretation_description":"not provided","version":"1","assertion_type":"variation to disease","variation_id":"42540","clinical_assertion_observation_ids":["SCV000606931.0"],"submitted_assembly":"GRCh37"}
